We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-15.22%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$6.61B
AUM Growth
+$4.82B
Cap. Flow
+$4.36B
Cap. Flow %
65.91%
Top 10 Hldgs %
81.66%
Holding
104
New
21
Increased
10
Reduced
22
Closed
18

Top Buys

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.59B
2
YHOO
Yahoo Inc
YHOO
+$66.1M
3
EQC
Equity Commonwealth
EQC
+$24.8M
4
SNDK
SANDISK CORP
SNDK
+$20.5M
5
NYT icon
New York Times
NYT
+$18.5M

Top Sells

Rank Stock Value
1
ONIT
Onity Group
ONIT
+$30.2M
2
JD icon
JD.com
JD
+$26.2M
3
GDOT icon
Green Dot
GDOT
+$14.9M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$11.7M
5
CASC
Cascadian Therapeutics, Inc.
CASC
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 29.86%
2 Consumer Discretionary 2.36%
3 Energy 1.23%
4 Real Estate 0.93%
5 Financials 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYAX
51
DELISTED
DYAX CORPORATION
DYAX
$9.87M 0.15%
372,510
-225,356
-38% -$5.97M
JD icon
52
JD.com
JD
$40.8B
$9.51M 0.14%
278,970
-770,130
-73% -$26.2M
MRTX
53
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$9.21M 0.14%
292,522
-163,944
-36% -$4.83M
MTG icon
54
MGIC Investment
MTG
$6.27B
$7.97M 0.12%
700,000
-525,716
-43% -$5.62M
ADAP
55
DELISTED
Adaptimmune Therapeutics
ADAP
$6.42M 0.1%
+350,000
New +$6.01M
ZX
56
DELISTED
China Zenix Auto Internatl Ltd
ZX
$5.34M 0.08%
6,074,805
– –
JPM icon
57
JPMorgan Chase
JPM
$939B
$5M 0.08%
+73,812
New +$4.82M
WFC icon
58
Wells Fargo
WFC
$261B
$4.92M 0.07%
+87,397
New +$4.87M
C icon
59
Citigroup
C
$222B
$4.84M 0.07%
+87,689
New +$4.77M
FSLR icon
60
PUT
First Solar
FSLR
$21.8B
$4.7M 0.07%
100,000
– –
MDVN
61
DELISTED
MEDIVATION, INC.
MDVN
$4.31M 0.07%
75,428
– –
TCON
62
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$4.1M 0.06%
1,842
– –
INTC icon
63
Intel
INTC
$466B
$3.57M 0.05%
117,400
– –
PTN
64
Palatin Technologies
PTN
$13.7M
$2.95M 0.04%
3,788
+992
+35% +$1.19M
OCRX
65
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.24M 0.03%
590,127
– –
XBI icon
66
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$2.14M 0.03%
+25,416
New +$1.98M
CASC
67
DELISTED
Cascadian Therapeutics, Inc.
CASC
$1.75M 0.03%
77,791
-642,503
-89% -$10.2M
VNET
68
VNET Group
VNET
$2.05B
$1.06M 0.02%
+51,638
New +$1.03M
ICPT
69
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.03M 0.02%
4,251
– –
ONCE
70
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$452K 0.01%
7,500
– –
MOLG
71
DELISTED
MOL GLOBAL INC SPONSORED ADR
MOLG
$256K ﹤0.01%
167,167
-1,522,123
-90% -$3.08M
QUNR
72
DELISTED
Qunar Cayman Islands Limited
QUNR
$214K ﹤0.01%
+5,000
New +$234K
ADVM
73
DELISTED
Adverum Biotechnologies
ADVM
– –
-9,115
Closed -$3.69M
ASPS icon
74
Altisource Portfolio Solutions
ASPS
$65.4M
– –
-77,004
Closed -$7.93M
AWI icon
75
Armstrong World Industries
AWI
$6.86B
– –
-65,800
Closed -$3.78M
1 2
3
4

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q2 2015 Portfolio in Review

As of Q2 2015, QVT Financial held 104 positions worth $6.61B, up 268% from $1.8B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

QVT Financial deployed $4.36B of net new capital in Q2 2015, opening 21 new positions and adding to 10 existing holdings. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.53B.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was JD.com, an estimated $26.2M trimmed.

  • QVT Financial's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.53B.
  • QVT Financial added most to LL Flooring Holdings, Inc. in Q2 2015, an estimated $13.6M increase.
  • QVT Financial's biggest Q2 2015 reduction was JD.com, cutting an estimated $26.2M.
  • QVT Financial fully exited Onity Group in Q2 2015, selling an estimated $30.2M.
  • QVT Financial's ten largest holdings make up 82% of its $6.61B portfolio in Q2 2015.
  • QVT Financial opened 21 new positions and closed 18 in Q2 2015.
  • QVT Financial's portfolio value rose 268% quarter-over-quarter to $6.61B.

Based on QVT Financial's 13F filing for Q2 2015, filed 14 Aug 2015.